Ceftriaxone 2 gram Add-Vantage in 100 mL 0.45% NS bag, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance
Prescription and over-the-counter medications
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance.
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance
Invisiblu International
Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance.
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance.
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance.
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance.
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance
Baptist Health Medical Towers Pharmacy and Infusion Services
Lack of Sterility Assurance
CGMP Deviations: active pharmaceutical ingredient intermediates failed specifications.